MedTrace Logo

MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)

NCT03870802 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-01-25

No results posted yet for this study

Summary

Monocentric, observational and prospective study in adult women having an early-stage breast cancer without genetic risk.

The main objective is to characterize quantitatively and qualitatively, after solitary confinement, the resident breast stem cells and the immune system cells infiltrated in the mammary gland in women:

* With a moderate risk of breast cancer progression (women with an early "Luminal A" tumor) = Group A.
* With a high risk of breast cancer progression (women with an early "Luminal B" or basal tumor) = Group B.

Conditions

Interventions

OTHER

Characterization of breast stem & immune system cells infiltrated in the mammary gland

Isolation, quantification and characterization of breast stem and immune cells of samples obtained during the prophylactic mastectomy in women presenting different tumor progression risks.

Sponsors & Collaborators

  • Centre Leon Berard

    lead OTHER

Principal Investigators

  • DELAY Emmanuel, MD · Centre Leon Berard

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-22
Primary Completion
2024-02-22
Completion
2024-11-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03870802 on ClinicalTrials.gov